Safety, Tolerability and Efficacy Study to Evaluate Subjects With Mild Cognitive Impairment
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if different doses of Investigational Drug are safe,
tolerable, and if they have an effect on Mild Cognitive Impairment (MCI).